Corelation of distance of breast tumor to nipple areola with axillary node involvement.
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/11/060190
- Lead Sponsor
- Aditya Sriharsha Pedaprolu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients admitted at A.V.B.R.H for lump in breast.
2.Female patients aged 18 or older.
3.Female breast cancer patients exhibiting intact, uninvaded skin of the nipple and areola.
4.Individuals diagnosed pathologically and radiologically with early-stage invasive breast cancer, devoid of distant metastasis.
5.Patients who have not previously undergone neoadjuvant chemotherapy, endocrine therapy, or targeted therapy.
6.Patients who express willingness to undergo Modified Radical Mastectomy.
7.Patients with no history of prior breast or axillary surgery.
8.Patients classified as T1 or T2 based on the 8th edition of the AJCC TNM staging system.
Pregnant status
Prior occurrence of any malignant tumor within the last five years
History of previous breast surgery
Diagnosis of multi-center, multifocal, or bilateral breast cancer, as well as ductal carcinoma in situ
The presence of severe systemic illness or dysfunction in any organ
Patients currently receiving or having received adjuvant chemotherapy, endocrine therapy, or targeted therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The decision to perform or avoid axillary clearance can be determined by assessing the tumor location and measuring the distance between the tumor and the nipple-areolar complex.Timepoint: 3 month pre and post operative period
- Secondary Outcome Measures
Name Time Method n/aTimepoint: n/a